Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following two upcoming conferences:

BTIG 3rd Annual Ophthalmology Day Format: Fireside Chat (Virtual) Date/Time: Monday, November 27, 2023, at 1:30 p.m. ET

Piper Sandler 35th Annual Healthcare Conference (The Lotte New York Palace, New York, NY) Format: Fireside Chat (In-Person) Date/Time: Thursday, November 30, 2023, at 8:00 a.m. ET

Harrow management will be available for one-on-one meetings during both conferences. Investors interested in meeting with management should contact their BTIG or Piper Sandler representative to request a meeting.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year. For more information about Harrow, please visit harrow.com.

Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737

Harrow (NASDAQ:HROW)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Harrow 차트를 더 보려면 여기를 클릭.
Harrow (NASDAQ:HROW)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Harrow 차트를 더 보려면 여기를 클릭.